Chinese herbal formula for mild to moderate psoriasis
Part of Skin clinical trials.
This trial tests an herbal formula called Shuiniujiao Dihuang Decoction for people with mild to moderate plaque psoriasis. It may help reduce psoriasis symptoms without using stronger medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate plaque psoriasis with a PASI score between 3 and 12.
- You have not used systemic psoriasis treatments (like pills or injections) in the last 6 months.
- You have not used topical psoriasis treatments (like creams or ointments) in the last 14 days.
- You have not taken antibiotics, probiotics, or prebiotics in the last 30 days.
- You have not had UV light therapy for psoriasis in the last 30 days.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SHR-1139 for people with moderate-to-severe plaque psoriasis. The goal is to see if it can safely improve your skin condition.
This trial tests a traditional Chinese herbal formula (Modified Qing-Ying Decoction) for children ages 4 to 17 with moderate-to-severe eczema (atopic dermatitis). The study aims to see if this herbal treatment can improve skin dryness, redness, and itching, especially for those with dry, scaly patches.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.